Form C-U Revolution MD, Inc

  
    C-U
    
      
        
          0001893460
          XXXXXXXX
        
        020-29465
      
      LIVE
      
        false
        false
        false
      
    
  
  
    
      At the close of the offering, the issuer closed on $40,648 and 23,197 number of securities.
      
        Revolution MD, Inc
        
          Corporation
          NV
          10-01-2018
        
        
          5600 CROOKED PINE LANE
          KNOXVILLE
          TN
          37921
        
        http://rev-md.com/
      
      N
      StartEngine Capital, LLC
      0001665160
      007-00007
    
    
      7 - 13 percent
      We charge 2% commission paid in equity or securities at the same rate as this offering.
      Common Stock
      5000
      2.00000
      N/A
      10000.00
      Y
      Other
      At issuer's discretion, with priority given to StartEngine Owners
      1070000.00
      07-28-2022
    
    
      4.00
      14324.00
      5017.00
      12260.00
      3693.00
      0.00
      0.00
      2552.00
      0.00
      10210.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      -89253.00
      -101611.00
      AL
      AK
      AZ
      AR
      CA
      CO
      CT
      DE
      DC
      FL
      GA
      HI
      ID
      IL
      IN
      IA
      KS
      KY
      LA
      ME
      MD
      MA
      MI
      MN
      MS
      MO
      MT
      NE
      NV
      NH
      NJ
      NM
      NY
      NC
      ND
      OH
      OK
      OR
      PA
      PR
      RI
      SC
      SD
      TN
      TX
      UT
      VT
      VA
      WA
      WV
      WI
      WY
    
    
      
        Revolution MD, Inc
        Joshua Kimmel
        President and Founder
      
      
        
          Joshua Kimmel
          President and Founder
          08-15-2022
        
        
          Ken Greenwood
          CTO
          08-15-2022
        
      
    
  

You May Also Be Interested In

• Danske Bank A/S, transactions by persons discharging managerial responsibilities
• Zayo Group Appoints New CEO of Zayo Europe
• Amarna Therapeutics announces appointment of Aurelia Caparrós as new Chief Business Officer